CoChat

Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy

Open access
SERRANO, MARÍA JOSÉ, ROVIRA, PEDRO SÁNCHEZ, MARTÍNEZ-ZUBIAURRE, I., RODRIGUEZ, MIGUEL DELGADO, FERNÁNDEZ, MÓNICA, LORENTE, JOSE A. · 2012 · Experimental and Therapeutic Medicine
Cited by 37

The DOI matches its Crossref record.

Abstract

At present, the majority of patients with breast cancer are diagnosed at early stages of disease development. However, a considerable number of such cases develop secondary malignancies after a relatively short period of time. The presence of circulating tumor cells (CTCs) has been proposed as a strong biomarker to predict disease recurrence in metastatic breast cancer. However, the prognostic significance is not clear in early breast cancer. We present results on CTC determination in peripheral blood in non-metastatic breast cancer patients in the context of neoadjuvant treatment. Twenty-six breast cancer patients, scheduled for neoadjuvant therapy, were enrolled in a prospective study, of which 24 were able to complete therapy. CTC assessment was performed by sorting out cytokeratin-positive cells from 10 ml of peripheral blood using immunomagnetic separation, followed by immunocytochemical characterization of cells. Seventeen blood samples out of 24 patients were CTC-positive when collected prior to neoadjuvant chemotherapy. No significant correlations were found between the presence of CTCs and lymph node status (p=0.1), histological type (p=0.802), stage (p=0.43) or overall survival (OS) (p=0.599). Thirteen CTC-positive samples were observed in blood samples collected after treatment. Univariate analyses revealed that the presence of CTCs was related to OS when the detection was positive both before and after treatment (p=0.023). CTCs can be a strong prognostic marker in early breast cancer. The persistence of CTCs before and after treatment can identify a subpopulation of patients with an increased risk of recurrence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/etm.2012.540

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 37

Metadata

Authors
SERRANO, M. J., ROVIRA, P. S., MARTÍNEZ-ZUBIAURRE, I., RODRIGUEZ, M. D., FERNÁNDEZ, M., & LORENTE, J. A.
Venue
Experimental and Therapeutic Medicine
Published
2012-04-05
Volume
4
Issue
1
Pages
43-48
ISSN
  • 1792-0981 (ISSN-L)
  • 1792-1015
OpenAlex
W2021210206
Cited by
37
References
0
FWCI
1.41
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy. https://app.cochat.ai/papers/10.3892/etm.2012.540
The paper
SERRANO, M. J., ROVIRA, P. S., MARTÍNEZ-ZUBIAURRE, I., RODRIGUEZ, M. D., FERNÁNDEZ, M., & LORENTE, J. A. (2012). Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy. Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2012.540

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.